Identification of a novel LRRC4C‐ALK fusion in lung adenocarcinoma and outcome of the response to anaplastic lymphoma kinase inhibitors. (8th February 2021) - Wang, Hongbiao; Li, ZhiFeng; Qi, Xiaofang; Wang, Wenjing; Lin, Yingcheng